Revision as of 14:47, 5 December 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 444071775 of page Prostaglandin_H2 for the Chem/Drugbox validation project (updated: 'CASNo'). |
Latest revision as of 07:56, 16 September 2024 edit Azn bookworm10 (talk | contribs)Extended confirmed users1,274 editsm formatting |
Line 1: |
Line 1: |
|
|
{{DISPLAYTITLE:Prostaglandin H<sub>2</sub>}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
|
| verifiedrevid = 444070236 |
|
| verifiedrevid = 464218126 |
⚫ |
|ImageFile=Prostaglandin H2 skeletal.svg |
|
|
|
| Name = Prostaglandin H<sub>2</sub><ref name=HMDB/> |
⚫ |
|ImageSize= |
|
|
|
| Reference = |
⚫ |
|IUPACName= |
|
|
⚫ |
| ImageFile = Prostaglandin H2 skeletal.svg |
|
|OtherNames= |
|
|
⚫ |
| ImageSize = |
⚫ |
|Section1= {{Chembox Identifiers |
|
|
⚫ |
| IUPACName = |
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
|
|
| OtherNames = PGH<sub>2</sub>, Endoperoxide H<sub>2</sub>, Prostaglandin R<sub>2</sub> |
|
|
| SystematicName = |
|
⚫ |
| Section1 = {{Chembox Identifiers |
|
|
| IUPHAR_ligand = 4483 |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 392800 |
|
| ChemSpiderID = 392800 |
|
| InChI = 1/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 |
|
| InChI = 1/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 |
Line 15: |
Line 20: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = YIBNHAJFJUQSRA-YNNPMVKQSA-N |
|
| StdInChIKey = YIBNHAJFJUQSRA-YNNPMVKQSA-N |
|
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
| CASNo = <!-- blanked - oldvalue: 42935-17-1 --> |
|
|
|
| CASNo=42935-17-1 |
⚫ |
| PubChem = 445049 |
|
|
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = J670X3LRU2 |
|
⚫ |
| PubChem = 445049 |
|
|
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|
| ChEBI = 15554 |
|
| ChEBI = 15554 |
|
| SMILES = O=C(O)CCC/C=C\C21OO(C1)2/C=C/(O)CCCCC |
|
| SMILES = O=C(O)CCC/C=C\C21OO(C1)2/C=C/(O)CCCCC |
|
| MeSHName=Prostaglandin+H2 |
|
| MeSHName=Prostaglandin+H2 |
|
}} |
|
}} |
|
|Section2= {{Chembox Properties |
|
| Section2 = {{Chembox Properties |
|
| Formula=C<sub>20</sub>H<sub>32</sub>O<sub>5</sub> |
|
| Formula=C<sub>20</sub>H<sub>32</sub>O<sub>5</sub> |
|
| MolarMass=352.465 g/mol |
|
| MolarMass=352.465 g/mol |
|
| Appearance= |
|
| Appearance= |
|
| Density= |
|
| Density=1.129 ± 0.06 g/mL |
|
| MeltingPt= |
|
| MeltingPt= |
|
| BoilingPt= |
|
| BoilingPt=490 ± 40.0 °C |
|
| Solubility= |
|
| Solubility=0.034 g/L |
|
}} |
|
}} |
|
|Section3= {{Chembox Hazards |
|
| Section3 = {{Chembox Hazards |
|
| MainHazards= |
|
| MainHazards= |
|
| FlashPt= |
|
| FlashPt= |
|
|
| AutoignitionPt = |
|
| Autoignition= |
|
|
}} |
|
}} |
|
|
| Section4 = |
|
|
| Section5 = |
|
|
| Section6 = |
|
}} |
|
}} |
|
|
|
|
|
'''Prostaglandin H<sub>2</sub>''' ('''PGH<sub>2</sub>'''), or '''prostaglandin H2''' ('''PGH2'''), is a type of ] and a precursor for many other biologically significant molecules. It is synthesized from ] in a reaction catalyzed by a ] enzyme.<ref>{{cite journal | vauthors = van der Donk WA, Tsai AL, Kulmacz RJ | title = The cyclooxygenase reaction mechanism | journal = Biochemistry | volume = 41 | issue = 52 | pages = 15451–8 | date = December 2002 | pmid = 12501173 | doi = 10.1021/bi026938h }}</ref> The conversion from ] to prostaglandin H<sub>2</sub> is a two-step process. First, ] catalyzes the addition of two free oxygens to form the ] bridge and a peroxide functional group to form ] (PGG<sub>2</sub>).<ref>{{Cite journal|last1=Salomon|first1=Robert G.|last2=Miller|first2=Donald B.|last3=Zagorski|first3=Michael G.|last4=Coughlin|first4=Daniel J. | name-list-style = vanc |date= October 1984 |title=Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH<sub>2</sub> and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution|journal=Journal of the American Chemical Society |volume=106|issue=20|pages=6049–6060|doi=10.1021/ja00332a049|issn=0002-7863}}</ref> Second, ] reduces the peroxide functional group to a ], forming prostaglandin H<sub>2</sub>. Other peroxidases like ] have been observed to reduce PGG<sub>2</sub> to PGH<sub>2</sub>.<ref>{{cite journal | vauthors = Hla T, Neilson K | title = Human cyclooxygenase-2 cDNA | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 89 | issue = 16 | pages = 7384–8 | date = August 1992 | pmid = 1380156 | pmc = 49714 | doi = 10.1073/pnas.89.16.7384 | bibcode = 1992PNAS...89.7384H | doi-access = free }}</ref> PGH<sub>2</sub> is unstable at room temperature, with a half life of 90–100 seconds,<ref name=HMDB>{{Cite HMDB|author1-link=David S. Wishart|url=http://www.hmdb.ca/metabolites/HMDB0001381|title=Showing metabocard for Prostaglandin H2 (HMDB0001381)}}</ref> so it is often converted into a different prostaglandin. |
|
|
|
|
|
] |
|
|
|
|
|
It is acted upon by: |
|
|
* ] to create ] |
|
|
* ] to create ] and 12-(S)-hydroxy-5Z,8E,10E-heptadecatrienoic acid (HHT) (see ]) |
|
|
* ] to create ] |
|
|
* ] to create ] |
|
|
|
|
|
It rearranges non-enzymatically to: |
|
|
* A mixture of 12-(S)-hydroxy-5Z,8E,10E-heptadecatrienoic acid (HHT) and 12-(S)-hydroxy-5Z,8Z,10E-heptadecatrienoic acid (see ]) |
|
|
|
|
|
Functions of prostaglandin H<sub>2</sub>: |
|
|
* regulating the constriction and dilation of blood vessels |
|
|
* stimulating platelet aggregation |
|
|
**binds to ] on platelets' cell membranes to trigger platelet migration and adhesion to other platelets.<ref>{{cite journal | vauthors = Woodward DF, Jones RL, Narumiya S | title = International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress | journal = Pharmacological Reviews | volume = 63 | issue = 3 | pages = 471–538 | date = September 2011 | pmid = 21752876 | doi = 10.1124/pr.110.003517 | doi-access = free }}</ref> |
|
|
|
|
|
Effects of ] on prostaglandin H<sub>2</sub>: |
|
|
* Aspirin has been hypothesized to block the conversion of arachidonic acid to prostaglandin |
|
|
|
|
|
] |
|
|
{{clear }} |
|
|
|
|
|
== References == |
|
|
{{Reflist}} |
|
|
|
|
|
{{Prostaglandins}} |
|
|
{{Prostanoidergics}} |
|
|
|
|
|
] |
|
|
] |
|
|
|
|
|
{{biochemistry-stub}} |